Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
INO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.43%96.460.6%$473.94m
ABTAbbott Laboratories
0.15%68.510.8%$292.33m
ISRGIntuitive Surgical, Inc.
-1.48%556.472.4%$254.80m
TMOThermo Fisher Scientific Inc.
0.82%241.061.0%$248.28m
ALGNAlign Technology, Inc.
-1.56%379.946.3%$224.97m
BAXBaxter International Inc.
0.54%77.661.7%$213.28m
BDXBecton, Dickinson and Company
0.13%260.081.1%$211.41m
BSXBoston Scientific Corporation
-0.35%37.491.1%$206.07m
SYKStryker Corporation
-0.31%173.561.3%$181.81m
ABMDABIOMED, Inc.
0.05%376.753.3%$171.98m
TNDMTandem Diabetes Care, Inc.
-5.69%39.954.1%$159.90m
EWEdwards Lifesciences Corporation
1.88%148.701.2%$137.62m
DXCMDexCom, Inc.
-0.17%139.088.5%$132.89m
ZBHZimmer Biomet Holdings, Inc.
-0.48%129.831.7%$125.95m
XRAYDENTSPLY International Inc.
1.10%38.613.0%$105.32m

Company Profile

Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.